Kossan Rubber Industries Bhd (KSRBF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 17.33 Million MYR | -79.25% |
| 2022 | 83.55 Million MYR | -66.82% |
| 2021 | 251.8 Million MYR | -55.88% |
| 2020 | 570.67 Million MYR | -1.29% |
| 2019 | 578.11 Million MYR | 13.65% |
| 2018 | 508.68 Million MYR | 28.21% |
| 2017 | 396.74 Million MYR | 123.54% |
| 2016 | 177.48 Million MYR | -20.51% |
| 2015 | 223.29 Million MYR | 8.34% |
| 2014 | 206.09 Million MYR | 21.97% |
| 2013 | 168.97 Million MYR | -15.09% |
| 2012 | 199 Million MYR | 24.41% |
| 2011 | 159.96 Million MYR | -10.01% |
| 2010 | 177.75 Million MYR | -14.05% |
| 2009 | 206.8 Million MYR | -8.86% |
| 2008 | 226.9 Million MYR | 22.18% |
| 2007 | 185.7 Million MYR | 23.52% |
| 2006 | 150.34 Million MYR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 23.35 Million MYR | 141.66% |
| 2024 Q1 | 9.66 Million MYR | -44.26% |
| 2023 Q2 | 43.1 Million MYR | -12.38% |
| 2023 Q1 | 49.19 Million MYR | -41.13% |
| 2023 Q4 | 17.33 Million MYR | -44.7% |
| 2023 Q3 | 31.35 Million MYR | -27.26% |
| 2023 FY | 17.33 Million MYR | -79.25% |
| 2022 Q4 | 83.55 Million MYR | -42.19% |
| 2022 Q2 | 209.33 Million MYR | -6.06% |
| 2022 Q1 | 222.84 Million MYR | -11.5% |
| 2022 FY | 83.55 Million MYR | -66.82% |
| 2022 Q3 | 144.52 Million MYR | -30.96% |
| 2021 Q3 | 318.82 Million MYR | -12.28% |
| 2021 Q4 | 251.8 Million MYR | -21.02% |
| 2021 Q1 | 495.55 Million MYR | -13.16% |
| 2021 FY | 251.8 Million MYR | -55.88% |
| 2021 Q2 | 363.44 Million MYR | -26.66% |
| 2020 Q3 | 535.95 Million MYR | -7.74% |
| 2020 Q1 | 657.16 Million MYR | 13.68% |
| 2020 Q2 | 580.91 Million MYR | -11.6% |
| 2020 Q4 | 570.67 Million MYR | 6.48% |
| 2020 FY | 570.67 Million MYR | -1.29% |
| 2019 FY | 578.11 Million MYR | 13.65% |
| 2019 Q4 | 578.11 Million MYR | -1.42% |
| 2019 Q1 | 561.05 Million MYR | 10.3% |
| 2019 Q2 | 592.99 Million MYR | 5.69% |
| 2019 Q3 | 586.42 Million MYR | -1.11% |
| 2018 Q4 | 508.68 Million MYR | 1.82% |
| 2018 Q3 | 499.56 Million MYR | -4.2% |
| 2018 Q1 | 422.79 Million MYR | 6.57% |
| 2018 FY | 508.68 Million MYR | 28.21% |
| 2018 Q2 | 521.48 Million MYR | 23.34% |
| 2017 Q1 | 294.48 Million MYR | 65.92% |
| 2017 FY | 396.74 Million MYR | 123.54% |
| 2017 Q4 | 396.74 Million MYR | 20.61% |
| 2017 Q3 | 328.96 Million MYR | 10.98% |
| 2017 Q2 | 296.41 Million MYR | 0.66% |
| 2016 Q1 | 217.95 Million MYR | -2.39% |
| 2016 FY | 177.48 Million MYR | -20.51% |
| 2016 Q2 | 241.21 Million MYR | 10.67% |
| 2016 Q3 | 221.97 Million MYR | -7.98% |
| 2016 Q4 | 177.48 Million MYR | -20.04% |
| 2015 Q2 | 207.83 Million MYR | -1.9% |
| 2015 Q3 | 239.36 Million MYR | 15.17% |
| 2015 Q4 | 223.29 Million MYR | -6.72% |
| 2015 FY | 223.29 Million MYR | 8.34% |
| 2015 Q1 | 211.84 Million MYR | 2.79% |
| 2014 Q4 | 206.09 Million MYR | 0.99% |
| 2014 Q1 | 215.32 Million MYR | 27.43% |
| 2014 Q3 | 204.07 Million MYR | 0.65% |
| 2014 Q2 | 202.75 Million MYR | -5.84% |
| 2014 FY | 206.09 Million MYR | 21.97% |
| 2013 Q1 | 178.52 Million MYR | -10.29% |
| 2013 FY | 168.97 Million MYR | -15.09% |
| 2013 Q4 | 168.97 Million MYR | -2.98% |
| 2013 Q3 | 174.16 Million MYR | -1.31% |
| 2013 Q2 | 176.47 Million MYR | -1.15% |
| 2012 Q3 | 156.23 Million MYR | 1.16% |
| 2012 FY | 199 Million MYR | 24.41% |
| 2012 Q2 | 154.43 Million MYR | 12.02% |
| 2012 Q4 | 199 Million MYR | 27.38% |
| 2012 Q1 | 137.86 Million MYR | 0.0% |
| 2011 FY | 159.96 Million MYR | -10.01% |
| 2010 FY | 177.75 Million MYR | -14.05% |
| 2009 FY | 206.8 Million MYR | -8.86% |
| 2008 FY | 226.9 Million MYR | 22.18% |
| 2007 FY | 185.7 Million MYR | 23.52% |
| 2006 FY | 150.34 Million MYR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -3367.6% |
| Ansell Limited | 855.59 Million USD | 97.974% |
| Ansell Limited | 857.2 Million USD | 97.977% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 22.638% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -82718.247% |
| Psykey, Inc. | 1.01 Million USD | -1615.614% |
| ConvaTec Group Plc | 1.31 Billion USD | 98.677% |
| ConvaTec Group Plc | 1.31 Billion USD | 98.679% |
| Encision Inc. | 1.33 Million USD | -1200.478% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -650.98% |
| Innovative MedTech Inc. | 1.87 Million USD | -823.106% |
| LifePoint, Inc. | 446.74 Thousand USD | -3781.005% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -221.42% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -692.051% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -7045.448% |
| SmileDirectClub, Inc. | 871.79 Million USD | 98.011% |
| Sector 10, Inc. | 164 Thousand USD | -10471.951% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 97.428% |
| SheerVision, Inc. | 75 Thousand USD | -23017.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -2193.42% |
| Vasamed, Inc. | 23.45 Thousand USD | -73836.034% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -526.515% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -2093.298% |